Related Experiment Video
Updated: Jun 29, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
ASO Author Reflections: Neoadjuvant Therapy and Post-Recurrence Overall Survival in Intrahepatic Cholangiocarcinoma
Yawen Dong1,2, Patrick Starlinger3,4
1Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, USA. Yawen-dong@hotmail.com.
Annals of Surgical Oncology
|June 27, 2026
Summary
No abstract available in PubMed .
